Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0002 USD | -.--% |
|
-.--% | -.--% |
2019 | Roivant Sciences GmbH cancelled the acquisition of substantially all of the assets from PhaseRx, Inc. | CI |
2018 | PhaseRx, Inc. Bankruptcy Case Dismissed | CI |
1st Jan change | Capi. | |
---|---|---|
-.--% | 2.34K | |
+18.60% | 122B | |
+19.71% | 112B | |
-23.67% | 19.33B | |
-18.45% | 16.17B | |
-19.67% | 15.6B | |
-49.33% | 14.65B | |
+56.76% | 14.34B | |
+7.70% | 14B | |
+125.98% | 11.29B |
- Stock Market
- Equities
- PZRXQ Stock
- News PhaseRx, Inc.
- Phaserx, Inc. Announces Termination of Michael Houston as Chief Scientific Officer